June 28, 2004

Formed in 2000, the alliance makes sophisticated core technologies available on a fee-for-service basis to biotech and pharmaceutical firms, to entrepreneurs and to researchers. By creating greater access to these technologies, the alliance serves as a catalyst for biotech research-and-development activities in the life-science industry ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.